Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-?B ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma (Q57904843)
Jump to navigation
Jump to search
scientific article published on 01 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-?B ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma |
scientific article published on 01 December 2006 |
Statements
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma (English)
Evangelos Terpos
Amin Rahemtulla
Kostas Zervas
Athanasios Anagnostopoulos
Anastasia Pouli
Eirini Katodritou
Evgenia Verrou
Elisavet-Christine Vervessou
Deborah J Heath
Andrew Chantry
1 December 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference